B
Biao Chen
Researcher at McMaster University
Publications - 11
Citations - 1684
Biao Chen is an academic researcher from McMaster University. The author has contributed to research in topics: Dentate gyrus & Gene expression. The author has an hindex of 11, co-authored 11 publications receiving 1592 citations.
Papers
More filters
Journal ArticleDOI
Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication.
TL;DR: Findings are consistent with recent studies measuring CREB levels in this same subject sample, and support current animal and cellular models of antidepressant function.
Journal ArticleDOI
Desipramine treatment reduces the long-term behavioural and neurochemical sequelae of early-life maternal separation.
TL;DR: It is reported here that maternally separated mice showed significantly shorter swim times on the forced swim test and significantly lower levels of brain-derived neurotrophic factor in dentate gyrus and CA3 regions of the hippocampus compared to control mice when assessed in adulthood.
Journal ArticleDOI
Regulation of ER stress proteins by valproate: therapeutic implications
TL;DR: Results show that ER stress proteins are increased in frontal and parietal cortex, as well as regions of the hippocampus in rat brain following chronic treatment with VPA, and the neuroprotective role of these proteins may also prove to be involved in the pathophysiology of bipolar disorder.
Journal ArticleDOI
Lithium and valproate differentially regulate brain regional expression of phosphorylated CREB and c-Fos.
TL;DR: The results suggest that lithium and VPA may act on different pathways to bring about their long-term prophylactic effects on bipolar disorder (BD), and the regulation of CREB phosphorylation may be relevant to lithium effect.
Journal ArticleDOI
Abnormalities in the cAMP signaling pathway in post-mortem brain tissue from the Stanley Neuropathology Consortium.
TL;DR: Observations are made on the relations between changes in second messenger systems, gene transcription, and clinical effects of current therapeutic regimens has implications for development of novel treatments of mood disorders.